Ruth W. Craig, PhD
Emeritus Professor of Pharmacology & Toxicology
Pharmacology & Toxicology
Pomona College, BA 1974
Boston University, MA 1980
SUNY - Buffalo, PHD 1984
Norris Cotton Cancer Center
Pharmacology and Toxicology Graduate Program
Program in Experimental and Molecular Medicine
HB 7650, Remsen
Geisel School of Medicine
Dept. of Pharmacology and Toxicology
Hanover NH 03755
• Control of cell viability by apoptosis-regulating genes such as Mcl-1.
• Causes of human mortality as they have evolved over the last several centuries.
Endocrinology Sections of Medical Pharmacology
Dr. Ruth Craig received her B.S. in Zoology from Pomona College. She completed M.A. and Ph.D. degrees in Pharmacology at, respectively, Boston University Medical School and the State University of New York. After postdoctoral training at Harvard Medical School, she moved to Johns Hopkins University School of Medicine and then Geisel School of Medicine at Dartmouth. In 2016, she earned the credential of Certified Genealogist® from the Board for Certification of Genealogists.
Nifoussi SK, Ratcliffe NR, Ornstein DL, Kasof G, Strack S, and Craig RW Inhibition of Protein Phosphatase 2A (PP2A) Prevents Mcl-1 Protein Dephosphorylation at the Thr-163/Ser-159 Phosphodegron, Dramatically Reducing Expression in Mcl-1-amplified Cells. J. Biological Chemistry 2014; 289(2): 21950-21959.
Gui J, Hu Z, Tsai C-Y, Song Y, Morales A, Huang L-H, Dmitrovsky E, Craig RW, and Usherwood E MCL1 Enhances the Survival of CD8+ Memory T Cells after Viral Infection. J Virology 2014; 89: 2405-2414.
Ruth Craig What Happened to the Jewish Infantryman? He Fought for Germany in World War I But Was He Able to Ship Out Before the Holocaust? Avotanu 37 (Fall 2016): 49–52.